Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2005
11/24/2005US20050261498 Preparation of 4-amino-1-naphthol ethers
11/24/2005US20050261371 Administering valproic acid or salts to treat Alzheimer's disease, amyotrophic lateral sclerosis, multiple sclerosis, stroke, and other nervous system disorders
11/24/2005US20050261306 Anti-neurodegenerative agents
11/24/2005US20050261303 e.g. (2R,5S)-4-(3-chloro-4-cyanophenyl)-N-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide; antiandrogenic agent
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261292 Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261277 Pentacyclic oxepines and derivatives thereof, compositions and methods
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005CA2567166A1 Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/24/2005CA2564954A1 Enantioselective phosphoramidite compounds and catalysts
11/24/2005CA2561525A1 Aryl sulfones and uses related thereto
11/23/2005EP1598350A1 Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis
11/23/2005EP1373232B1 Method for producing n-substituted 2,6-dialkyl morpholines
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1228337C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
11/23/2005CN1228333C Improved method for preparing N-alkyl morpholine
11/23/2005CN1228325C Biguanide derivatives
11/22/2005US6967199 Substituted diamine derivatives useful as motilin antagonists
11/22/2005CA2187174C .alpha.-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
11/17/2005WO2005109107A1 Composition for removing a (photo)resist
11/17/2005WO2005108384A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
11/17/2005WO2005108381A1 Synthesis and uses of synephrine derivatives
11/17/2005WO2005108378A2 Use of (4-alkylpiperazinyl) (phenyl) methanones in the treatment of alzheimer’s disease
11/17/2005WO2005108368A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/17/2005WO2005108351A1 Benzonitrile derivatives to treat musculoskeletal frailty
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005107464A2 Compounds and compositions as cathepsin s inhibitors
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
11/17/2005US20050256308 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
11/17/2005US20050256191 Nitroaniline-based alkylating agents and their use as prodrugs
11/17/2005US20050256161 Melanin concentrating hormone receptor antagonists
11/17/2005US20050256133 Thio-substituted arylmethanesulfinyl derivatives
11/17/2005US20050256132 Use of ER selective NF-kB inhibitors for the treatment of sepsis
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005US20050255151 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
11/17/2005US20050255055 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine
11/17/2005CA2568241A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2565544A1 Benzonitrile derivatives to treat musculoskeletal frailty
11/17/2005CA2564068A1 Use of (4-alkylpiperazinyl) (phenyl) methanones in the treatment of alzheimer's disease
11/16/2005EP1595863A1 Quaternary ammonium salts
11/16/2005EP1594836A1 Hydroxy-tetrahydro-naphthalenylurea derivatives
11/16/2005EP1421634B1 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/16/2005EP0873406B1 Protein induced by deprenyl
11/16/2005CN1696129A Novel process for the synthesis of carboxylic acid phenylamide
11/16/2005CN1696121A 4-[2-(artyl sulfo) benzyl]-1-derivative of aryl-piperazine, preparation method and application
11/16/2005CN1227242C Chemical synthesis of 1-chloroformyl-4-methylpiperazine hydrochloride
11/16/2005CN1227241C Arylpiperazines having activity at the serotnin 1A receptor
11/15/2005US6965038 Acylated aminothiol compound
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964963 Preparation of 4-amino-1-naphthol ethers
11/15/2005CA2130031C Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105766A2 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105735A1 Phenoxyacetic acid derivatives as ppar agonists
11/10/2005WO2005105725A1 Novel compounds, their preparation and use
11/10/2005WO2005105724A1 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/10/2005US20050250944 Synthesis and uses of synephrine derivatives
11/10/2005US20050250814 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/10/2005US20050250791 Process for preparing monoarylpiperazines
11/10/2005US20050250790 Novel sulfonic acid derivatives
11/10/2005US20050250768 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
11/10/2005US20050250758 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
11/10/2005US20050250744 Pharmaceutically active compounds and methods of use thereof
11/10/2005US20050250743 Ammonium salts of inositol hexaphosphate, and uses thereof
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005CA2649054A1 Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/09/2005EP1593679A1 3- Or 4-monosubstituted phenol derivatives useful as H3 ligands
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1593667A1 Amine derivative
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1592425A2 New arylpiperazinyl compounds
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1252166B1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1196403B1 Antipsychotic cyclic n-aralkyl amines
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide
11/09/2005CN1226265C Process for synthesis of cis-1-2-4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1)-phenoxy- ethyl-pyrrolidine
11/08/2005US6962929 Drugs such as 4-(N,N-Dimethylamino)-1-pentafluorophenyl-sulfonamidobenzene and/or prodrugs, used as anticarcinogenic agents, microbiocides or bactericides; tubulin inhibitors
11/03/2005WO2005103023A1 Phenylsulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase inhibitors
11/03/2005WO2005102989A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005WO2005070890A3 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
11/03/2005WO2005044201A3 Ph sensitive prodrugs of 2,6-diisopropylphenol
11/03/2005US20050245757 Method for the production of phenylalanine derivatives
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245745 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/03/2005US20050245602 Selective estrogen receptor modulators
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245534 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/03/2005US20050245522 Novel compounds
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 341